Preliminary study between Y chromosome haplogroups and chagasic cardiomyopathy manifestations in patients with Chagas disease

被引:1
|
作者
Lassen, Oscar [1 ]
Tabares, Sandra [2 ]
Bertolotto, Patricia [3 ]
Ojeda, Silvia [3 ]
Sembaj, Adela [2 ]
机构
[1] Cordoba Hosp, Semiol Dept UHMI 3, Chagas & Hypertens Off, Cordoba, Argentina
[2] UNC, Biochem & Mol Biol Dept, Sch Med, Cordoba, Argentina
[3] UNC, Sch Math Astron & Phys, Cordoba, Argentina
关键词
Chagas Disease; Cardiomyopathy; Y chromosome; CORONARY-ARTERY-DISEASE; RISK; STANDARDS; SEX;
D O I
10.1590/0037-8682-0566-2019
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Introduction: Among patients with Chagas disease, men have a higher risk of worse pathological symptoms than women. We aimed to explore the role of the Y chromosome in men diagnosed with Chagas disease and assess the relationship between their ancestry and disease status. Methods: In this comparative study, we analyzed 150 men with unrelated non-chagasic disease (nCD) and 150 men with unrelated chagasic disease (CD). We assessed the serological diagnosis of Chagas disease, biochemical parameters, thoracic X-rays, electrocardiogram, and transthoracic echocardiography and determined the haplogroup by analyzing a set of 17 microsatellites from the Y chromosome. We examined the associations between common Y chromosome haplogroups and the clinical parameters of risk by logistic regression. Results: For all patients, the most common haplogroups were R1b (43%), G2a (9%), and E1b1b (9%). The R1b and G2a haplogroup was more frequent in men with nCD and CD, respectively. As expected, we observed a high proportion of symptomatic patients in the CD group independent of the haplogroups. Men from both groups classified as having the R1b haplogroup showed less clinical evidence of disease. Multivariate analysis showed that CD patients without Rib were about five times more likely to have a cardio-thorax index >0.5% (OR [odds ratio] = 5.1, 95% CI [confidence interval] = 3.31-8.17). Men without the R1b haplogroup were 2.5 times more likely to show EcoCG alterations (OR = 2.50, 95% CI = 0.16-3.94). Conclusions: Our results provided evidence that the R1b haplogroup may have a potential protective cardiovascular effect for its carriers.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Chagas Disease in Mexico: Report of 14 Cases of Chagasic Cardiomyopathy in Children
    Maria Salazar-Schettino, Paz
    Cabrera-Bravo, Margarita
    Vazquez-Antona, Clara
    Zenteno, Edgar
    De Alba-Alvarado, Mariana
    Torres Gutierrez, Elia
    Guevara Gomez, Yolanda
    Gabriela Perera-Salazar, Maria
    Garcia de la Torre, Guadalupe
    Irene Bucio-Torres, Martha
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2016, 240 (03) : 243 - 249
  • [2] Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease
    Carod-Artal, FJ
    Vargas, AP
    Horan, TA
    Nunes, LGN
    STROKE, 2005, 36 (05) : 965 - 970
  • [3] Analysis of Y chromosome haplogroups in Parkinson's disease
    Grenn, Francis P.
    Makarious, Mary B.
    Bandres-Ciga, Sara
    Iwaki, Hirotaka
    Singleton, Andrew B.
    Nalls, Mike A.
    Blauwendraat, Cornelis
    BRAIN COMMUNICATIONS, 2022, 4 (06)
  • [4] Mitochondrial haplogroups in patients with rheumatoid arthritis: No association with disease and disease manifestations
    Duhn, Pernille Hurup
    Sode, Jacob
    Hagen, Christian Munch
    Christiansen, Michael
    Locht, Henning
    PLOS ONE, 2017, 12 (12):
  • [5] Lack of association between Y chromosome haplogroups and male infertility in Japanese men
    Carvalho, CMB
    Fujisawa, M
    Shirakawa, T
    Gotoh, A
    Kamidono, S
    Paulo, TF
    Santos, SEB
    Rocha, J
    Pena, SDJ
    Santos, FR
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 116A (02) : 152 - 158
  • [6] Anticoagulation in patients with cardiac manifestations of Chagas disease and cardioembolic ischemic stroke
    Monteiro, Jean M. C.
    San-Martin, Daniel L.
    Silva, Beatriz C. G.
    de Jesus, Pedro A. P.
    Oliveira-Filho, Jamary
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2018, 76 (01) : 22 - 25
  • [7] Defective production of interleukin 2 in patients with Chagas' disease. Purified IL-2 augments in vitro response in patients with chagasic cardiomyopathy
    Briceno, L
    Mosca, W
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 1996, 91 (05): : 601 - 607
  • [8] Predictors of Incident Heart Failure in Patients With Chronic Chagas Disease Cardiomyopathy
    da Cunha, Danton Machado
    Mediano, Mauro Felippe Felix
    Rimolo, Lorena dos Santos Marreto
    da Costa, Andrea Rodrigues
    Diogo, Danilo Bento
    Sangenis, Luiz Henrique Conde
    Veloso, Henrique Horta
    de Holanda, Marcelo Teixeira
    Hasslocher-Moreno, Alejandro Marcel
    da Cunha, Ademir Batista
    Saraiva, Roberto Magalhaes
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2025, 42 (05):
  • [9] Cellular therapy in Chagas' disease: potential applications in patients with chronic cardiomyopathy
    Soares, Milena B. P.
    Garcia, Simone
    Campos de Carvalho, Antonio Carlos
    dos Santos, Ricardo Ribeiro
    REGENERATIVE MEDICINE, 2007, 2 (03) : 257 - 264
  • [10] Predictors of Mortality in Patients with Dilated Cardiomyopathy: Relevance of Chagas Disease as an Etiological Factor
    Pereira Nunes, Maria do Carmo
    Barbosa, Marcia M.
    Ribeiro, Antonio Luiz P.
    Amorim Fenelon, Lucia Maria
    Rocha, Manoel D. C.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2010, 63 (07): : 788 - 797